SEC 13F Intelligence

Octagon Capital Advisors LP / CRDF

Octagon Capital Advisors LP’s Cardiff Oncology Inc Position

Does Octagon Capital Advisors LP own Cardiff Oncology Inc (CRDF)? Not currently — the last reported position was 982.8K shares worth $6M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q4 2021
Shares
982.8K
% of Portfolio
+1.15%
Quarters Held
5
position exited

Position History CRDF

Reported value by quarter
Q4 ’20: $12MQ4 ’20Q1 ’21: $6MQ1 ’21Q2 ’21: $7MQ2 ’21Q3 ’21: $7MQ3 ’21Q4 ’21: $6MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2021982.8K$6M+1.15%
Q3 2021982.8K$7M+1.61%
Q2 2021982.8K$7M+1.35%
Q1 2021650.0K$6M+2.27%
Q4 2020650.0K$12M+4.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of CRDF.